Mark Glickman: Medicare should keep pace with Alzheimer’s innovation

Mark Glickman argues that Medicare needs to adapt to the rapid advancements in Alzheimer’s treatment and research to better meet patient needs. As new therapies and innovations emerge, there's a growing call for Medicare to provide more comprehensive coverage to keep up with these scientific breakthroughs. This shift is crucial not just for patient care but also for the broader healthcare system, which is increasingly challenged by the growing Alzheimer’s population. By keeping pace with innovation, Medicare can offer better support to both patients and their families.